Cross Country Healthcare Inc (CCRN) is a publicly traded Healthcare sector company. As of May 21, 2026, CCRN trades at $13.08 with a market cap of $406.21M and a P/E ratio of -4.30. CCRN moved +0.08% today. Year to date, CCRN is +54.05%; over the trailing twelve months it is -4.93%. Its 52-week range spans $7.43 to $18.33. Analyst consensus is neutral with an average price target of $12.38. Rallies surfaces CCRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Knox Lane to Buy Cross Country Healthcare for $437 Million at 31% Premium: Cross Country Healthcare will be acquired by Knox Lane in an all-cash deal valued at $437 million, paying $13.25 per share. The offer represents a 31% premium to the May 6 closing price and anticipates closing in third quarter 2026 pending stockholder and regulatory approvals.
| Metric | Value |
|---|---|
| Price | $13.08 |
| Market Cap | $406.21M |
| P/E Ratio | -4.30 |
| EPS | $-3.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.33 |
| 52-Week Low | $7.43 |
| Volume | 25 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.00B |
| Net Income | $-98.63M |
| Gross Margin | 20.21% |
7 analysts cover CCRN: 0 strong buy, 0 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $12.38.